VitaSpring Biomedical Co. Ltd. VSBC
OTC PK
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 113.46% | -3.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 113.46% | -6.30% | |||
| Operating Income | -113.46% | 6.30% | |||
| Income Before Tax | -105.54% | 6.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -105.54% | 6.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -105.54% | 6.99% | |||
| EBIT | -113.46% | 6.30% | |||
| EBITDA | -118.26% | 6.38% | |||
| EPS Basic | -100.00% | 0.00% | |||
| Normalized Basic EPS | -150.00% | 0.00% | |||
| EPS Diluted | -100.00% | 0.00% | |||
| Normalized Diluted EPS | -150.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||